Former Editorial Board

Tomoyuki Abe

Department of Surgery, Onomichi General Hospital, Japan

Richard J. Ablin, PhD

Department of Pathology, The University of Arizona, Tucson, AZ, USA

Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, The Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center, Neurological Institute, Cleveland Clinic Cleveland, Ohio, USA

Yong Chan Ahn, MD, PhD

Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea

Hana Alguel, MD, MPH

Technical University of Munich, Munich, Germany

Karen S. Anderson, MD, PhD

Professor, Biodesign Institute, School of Life Sciences, Arizona State University, Tempe, Arizona, USA

Jean-Pierre Armand MD, MSc

Institut Gustave Roussy, Cancer Campus Grand Paris, France

Suhad M. Bahijri, BSc, PhD, FICN

Professor of Clinical Biochemistry and Nutrition, Department of Clinical Biochemistry, Head of Saudi Diabetes Research Group, Faculty of Medicine & King Fahd Medical Research Centre, King Abdulaziz University, Jeddah Saudi Arabia

Yung-Jue Bang, MD, PhD

Seoul National University College of Medicine; Biomedical Research Institute, Seoul National University Hospital, Korea

Tracy Batchelor, MD, MPH

Stephen E. and Catherine Pappas Center for Neuro-Oncology, Massachusetts General Hospital Co-Leader, Brain Cancer Program, Harvard Medical School; Giovanni Armenise - Harvard Professor of Neurology, Harvard Medical School, Boston, Massachusetts, USA

Andrea Belli, MD, PhD

Division of Surgical Oncology, Department of Abdominal Oncology, "Istituto Nazionale Tumori Fondazione G. Pascale"- IRCCS, Naples, Italy

Priscilla Kaliopi Brastianos, MD

Central Nervous System Metastasis Program; Divisions of Hematology/Oncology and Neuro-Oncology, Departments of Medicine and Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA

Antonio C Buzaid, MD

Centro Oncológico Antonio Ermírio de Moras, Hospital São José, Rua Martiniano de Carvalho,São Paulo, Brazil

Robert C. Bast

Vice President for Translational Research, UT MD Anderson Cancer Center, USA

Andrea Camerini, MD, PhD

Medical Oncology, Versilia Hospital and Istituto Toscano Tumori, Lido di Camaiore, Italy

Kenneth Cardona, MD, FACS

Division of Surgical Oncology, Winship Cancer Institute, Emory University, Atlanta, Georgia, USA

Lydia W. T. Cheung

School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, China

Melvin L.K. Chua

Division of Radiation Oncology, National Cancer Centre, Duke-NUS Graduate Medical School, Singapore

Cédric Coulouarn, PhD

Inserm UMR-1242, "Chemistry, Oncogenesis, stress, Signaling" (COSS), University of Rennes 1, Comprehensive Cancer Center Eugène Marquis, Rennes, France

James CS Chim

Department of Medicine, Queen Mary Hospital University of Hong Kong, Hong Kong, China

Shaheenah Dawood

Department of Medical Oncology, Mediclinic City Hospital, Comprehensive Cancer Center, Dubai Health Care City, Dubai, U.A.E

James J. Dignam, PhD

Professor of Biostatistics, Department of Public Health Sciences, The University of Chicago Biological Sciences, Illinois, USA

Christian Dittrich, MD

LBI-ACR VIEnna and ACR-ITR VIEnna, Center for Oncology and Haematology, Kaiser Franz Josef-Spital, Vienna, Austria

Don S. Dizon

Division of Medical Oncology, Department of Medicine, Lifespan Cancer Institute, Rhode Island Hospital, Providence, RI, USA

Prof Matteo Donadon

Associate Professor of Surgery, Director, Surgical Oncology Program, Department of General Surgery, University Maggiore Hospital

Traian Dumitrascu, MD, PhD

Department of General Surgery and Liver Transplantation, Fundeni Clinical Institute, Carol Davila University of Medicine and Pharmacy, Fundeni Street no 258, 022328 Bucharest, Romania

Andrew S. Epstein, MD

Gastrointestinal Oncology Service, Palliative Medicine Service, Memorial Sloan Kettering Cancer Center, New York, USA

Christina Fotopoulou

Department of Gynaecologic Oncology, Imperial College Healthcare NHS Trust, London, United Kingdom.

Junji Furuse, MD, PhD

Department of Medical Oncology, Kyorin University School of Medicine, Tokyo, Japan

Antonio Giorgio

Liver Unit and Interventional Ultrasound Unit , Athena Clinical Institute, Piedimonte Matese (CE), Italy

Joseph Gligorov

Breast Cancer Expert Center, APHP Tenon, IUC-UPMC Sorbonne University, Paris, France

David Goldstein, MBBS, FRACP, FRCP (UK)

Department of Medical Oncology, Prince of Wales Hospital, Randwick, Australia

Axel Grothey, MD

Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota, USA

Jun Guo, MD, PhD

Department of Melanoma & Renal Cancer, Peking University Cancer Hospital & Institute, Beijing, China

Rick L. Haas

Department of Radiotherapy, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Radiotherapy, The Leiden University Medical Center, Leiden, The Netherlands

Daniel G. Haller, MD, FACP, FASCO, FRCP (Gastrointestinal Cancer)

Abramson Cancer Center at the University of Pennsylvania, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA

Ho-Seong Han, MD, PhD

Professor of Department of Surgery, Seoul National University Bundang Hospital, Seoul National University, College of Medicine, 166 Gumi-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13620, Korea

Rupert Handgretinger, MD

Children’s University Hospital, Department Hematology/Oncology, University of Tuebingen, Hoppe-Seyler-Strasse 1, 72076 Tuebingen, Germany

Jitti Hanprasertpong, MD

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Prince of Songkla University, Songkhla, Thailand

Frank Stephen Hodi, Jr, MD

Harvard Medical School, Dana-Farber Cancer Institute, Melanoma Disease Center, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA

Gabriel N. Hortobagyi

Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

O. Hans Iwenofu

Department of Pathology & Laboratory Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA

N Gopalakrishna Iyer

Division of Surgical Oncology, National Cancer Centre, Singapore, Singapore

Long R Jiao, MD, FRCS

Hepato-Pancreato-Biliary (HPB) Surgical Unit, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London W12 0HS, UK

Elio Jovine, MD, FACS

Full Professor of Surgery, Department of General Surgery, University of Bologna Alma Mater Studiorum, Bologna, Italy

Virginia Kaklamani, MD, DSc

Division Hematology/Oncology, Northwestern University, Chicago, Illinois, USA

Tatsuo Kanda, MD, PhD

Associate Professor of Division of Gastroenterology and Hepatology, Department of Medicine, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan

Noriyuki Katsumata, MD

Department of Medical Oncology, Nippon Medical School Musashikosugi Hospital, Kawasaki, Kanagawa, Japan

Bhumsuk Keam MD, PhD

Seoul National University Hospital, Korea

Chok Siu Ho Kenneth, MBBS (HKU), MD (HK), MS (HK), MRCSEd, FRCSEd, FCSHK, FHKAM (Surgery)

Specialist in General Surgery, Honorary Clinical Associate Professor, Department of Surgery, LKS Faculty of Medicine, The University of Hong Kong, Honorary Consultant in General Surgery, Gleneagles Hong Kong Hospital, Hong Kong, China

Young Zoon Kim, MD, PhD

Neuro-Oncology Division, and Neurosurgical Department, Sungkyunkwan University School of Medicine, Samsung Changwon Hospital, Changwon, South Korea

Takefumi Komiya, MD, PhD

Medical Oncologist (Thoracic) Parkview Cancer Institute, Parkview Health Volunteer Clinical Assistant Professor, Indiana University School of Medicine, USA

Lin Kong, MD

Head of the Head/Neck and CNS Oncology Service at the Shanghai Proton and Heavy Ion Center (SPHIC), Shanghai, China

Ava Kwong, MBBS, BSc (St Andrews), PhD, FRCS (Edin), FRCS,FHKAM (Surgery), FCSHK

The University of Hong Kong and The University of Hong Kong-Shen Zhen Hospital, China; Department & Faculty of Medicine, The University of Hong Kong; Chairman, The Hong Kong Hereditary Breast Cancer Family Registry; Hong Kong Sanatorium and Hospital, China

Denis Lacombe, MD, MSC

EORTC Headquarters, Brussels, Belgium

Antonio Simone Laganà

Medical Doctor at the Department of Obstetrics and Gynecology, “Filippo Del Ponte” Hospital, University of Insubria, Varese, Italy

J. Jack Lee, PhD

Departments of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

Ning Liao, MD, PhD

Director, Department of Breast Cancer, Cancer Center, Guangdong General Hospital, Guangzhou, China

Ke Liu, MD, PhD

Office of Cellular, Tissue and Gene Therapies, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland, USA

Alexander V. Louie

Sunnybrook Health Science Centre, Department of Radiation Oncology, University of Toronto, Canada

H. Kim Lyerly, MD

Department of Surgery, Division of Surgical Sciences, Duke University Medical Center, Durham, North Carolina, USA

Brigette Ma, MD, MBBS (Hon), FRACP, FHKCM, FHKAM

Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, China; Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hong Kong, China

Nikolaos Machairas, MD, PhD

2nd Department of Propaedeutic Surgery, National and Kapodistrian University of Athens, Greece

Douglas McNeel, MD, PhD

UW Carbone Cancer Center, Department of Medicine, University of Wisconsin, Madison, Wisconsin, USA

Heriberto Medina-Franco, MD, FACS

Division of Surgery. Section of Surgical Oncology. National Institute of Medical Sciences and Nutrition, Mexico City, Mexico

Philippe Metellus, MD, PhD

Department of Neurosurgery, Clairval Hospital Center, Generale de Sante, Marseille , France

Yoshihiro Mise, MD, PhD

Department of Hepatobiliary-Pancreatic Surgery, Juntendo University Hospital, Tokyo, Japan

Daniela Molena, MD

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Luca Morelli, MD, FACS, FASCRS

General Surgery Unit, Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Italy

David Morris, MB, ChB, FRCS, FRCSE, MD, PhD, FRACS

Department of Surgery, Peritonectomy Unit, St George Hospital & University of New South Wales, Australia

Kazuhiko Nakagawa, MD, PhD

Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka-Sayama, Osaka, Japan

Yi-Qian Nancy You, MD, MHSc, FACS

Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Yangmin Ning, MD, PhD

Office of Oncology Drug Products, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA

Kazuto Nishio, MD, PhD

Department of Genome Biology, Kinki University Faculty of Medicine, Osaka, Japan

Masahiko Nishiyama, MD, PhD

Department of Molecular Pharmacology & Oncology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan

Kjell ÖBERG, MD, PhD

Department of Endocrine Oncology, Uppsala University Hospital, Uppsala, Sweden

Ken O’Byrne, MD

Department of Clinical and Medical Oncology, St James’s Hospital and Trinity College, Dublin, Ireland

Duilio Pagano, MD

Abdominal Transplantation Surgery, ISMETT-IRCCS UPMC, Italy

Matthias Preusser

Department of Medicine I, Comprehensive Cancer Center-CNS Unit, Medical University of Vienna, Vienna, Austria

Bo R. Rueda, PhD

Vincent Center for Reproductive Biology, Department of Obstetrics and Gynecology. Massachusetts General Hospital, Boston, Massachusetts, USA

Francesco Ricci

Institute Curie, PSL Research University, Department of Medical Oncology, Paris, France

Saul E. Rivkin

Swedish Cancert Institute; Marsha Rivkin Center for Ovarian Cancer Research, Seattle, Washington, USA.

Flavio Rizzolio, PhD

Natl Canc Inst CRO IRCSS, Dept Translat Res, Aviano, Italy

David P. Ryan, MD

Massachusetts General Hospital Cancer Center, Boston, Massachusetts, USA

Grzegorz S. Nowakowski

Division of Hematology, Mayo Clinic, Rochester, MN, USA

Hope S. Rugo, MD

Breast Oncology and Clinical Trials Education, University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, California, USA

Daniel J. Sargent, PhD (Statistics in Oncology Clinical Trials, 1970-2016)

Department of Biostatistics, Mayo Clinic, Rochester, Minnesota, USA

Kazunari Sasaki, MD

Department of general Surgery, Digestive Disease and Surgery Institute, Cleveland Clinic, Cleveland, Ohio, USA

Mark A. Schattner MD, FASGE, ASGF

Department of Medicine, Gastroenterology, Hepatology, and Nutrition Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Priyanka Sharma

University of Kansas Medical Center, Westwood KS 66205, USA

Junichi Shindoh, MD, PhD

Surgeon-in-chief, Hepatobiliary-pancreatic Surgery Division, Department of Gastroenterological Surgery, Toranomon Hospital, Tokyo, Japan

Wenru Song, MD, PhD

Department of Medicine, Division of Oncology, Stanford University Medical Center, Stanford, California, USA

Cosimo Sperti, MD

Department of Surgery, Oncology and Gastroenterology, 3rd Surgical Clinic, University of Padua, Via Giustiniani 2, 35128 Padua, Italy

Weijing Sun, MD, FACP

Division of Hematology-Oncology, Department of Medicine, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA, USA

Sandra M. Swain, MD, FACP

Washington Cancer Institute, Medstar Washington Hospital Center, Washington DC, USA

Kjetil Søreide, MD, PhD, FRCS (Edin), FACS

Consultant general and HPB surgeon, Department of Gastrointestinal Surgery, Stavanger University Hospital, Norway Professor of Surgery, Department of Clinical Medicine, University of Bergen, Norway Lead, Gastrointestinal Translational Research Unit, Laboratory for Molecular biology, Stavanger University Hospital, Norway